Clinical Trial Detail

NCT ID NCT03368963
Title TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Emory University
Indications

pancreatic adenocarcinoma

colorectal adenocarcinoma

cholangiocarcinoma

gastric adenocarcinoma

Therapies

MM-398 + Trifluridine-tipiracil hydrochloride

Age Groups: adult senior

No variant requirements are available.